San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Vividion’s Backers Give It Good Starting Point With $50M

A recent infusion of cash launched a local biotech out of stealth mode with the biggest VC backing of the year so far in San Diego.

By Brittany Meiling February 9, 2017 2:59 p.m. share »

DJO Global Getting into Software

Another local medical device firm is dabbling in software.

By Brittany Meiling February 9, 2017 2:35 p.m. share »

FDA Grants Angionetics' Therapeutic Candidate Fast-Track Status

Local gene therapy company Angionetics Inc. has been granted a Fast Track designation from the U.S. Food and Drug Administration for its lead drug candidate Generx.

By Brittany Meiling February 7, 2017 1:06 p.m. share »

GreatCall Leases New Location to Accommodate Expansion

San Diego-based GreatCall Inc. has leased a 61,000-square-foot space in Carlsbad it plans to expand into in May.

By John Cox February 7, 2017 6 a.m. share »
Tease photo

Group Buying Genoptix’s Diagnostic Business

Ownership of the Genoptix name is changing hands again as the company’s commercial laboratory is peeled off from its other operations in Carlsbad.

By Brittany Meiling February 6, 2017 midnight share »

Acadia's Stock Gets Boost From Speculation Over Possible Acquisition

The stock of San Diego drugmaker Acadia Pharmaceuticals Inc. is on the rise Feb. 3 following speculation of a takeover bid by Big Pharma AstraZeneca.

By Brittany Meiling February 3, 2017 1:20 p.m. share »

Ionis Earns $5 Million from Biogen

Local drugmaker Ionis Pharmaceuticals Inc. has earned $5 million in a milestone payment from Biogen, a global giant in biotechnology and one of Ionis’ many partners.

By Brittany Meiling February 2, 2017 3:51 p.m. share »

Vividion Therapeutics Raises $50 Million

Local biopharmaceutical company Vividion Therapeutics has raised $50 million in a Series A funding round. The funding was led by two top-tier venture capital firms, ARCH Venture Partners and Versant Ventures, and also included Cardinal Partners.

By Brittany Meiling February 2, 2017 3:48 p.m. share »

Illumina's Q4 Revenue of $619M Exceeds Expectations

Illumina Inc. exceeded Wall Street’s expectations Tuesday when the medtech company reported its fourth quarter revenue was up 5 percent.

By Brittany Meiling February 1, 2017 12:56 p.m. share »

Local CRO Strikes a Deal With Janssen

San Diego-based ChemDiv Inc. has entered a research collaboration with New Jersey-based Janssen Research & Development LLC to find promising targets that might lead to the development of medicines.

By Brittany Meiling January 31, 2017 5:02 p.m. share »

Scripps Women’s Heart Center Opens in La Jolla

A team of four women cardiologists will treat women’s hearts exclusively at a new medical facility in La Jolla.

By John Cox January 31, 2017 4:51 p.m. share »
Tease photo

Dawn Hocevar Chosen to Lead Women in Bio

Dawn Hocevar, vice president of national business development for San Diego-based BioSurplus, has been elected president and chairwoman of Women in Bio, a volunteer organization that advocates for women in the life sciences industry.

By Sarah de Crescenzo January 31, 2017 12:54 p.m. share »

Biocom’s C-Suite Expands as Organization Stretches North

Biocom’s expansion throughout California has led the life science trade group to promote two senior level employees to executive positions.

By Brittany Meiling January 31, 2017 11:33 a.m. share »

Regulus Stock Plummets as FDA Maintains Hold on Lead Drug

Local drugmaker Regulus Therapeutics Inc. watched its stock tank 42 percent Monday following unfavorable news from the U.S. Food and Drug Administration (FDA).

By Brittany Meiling January 30, 2017 3:58 p.m. share »

AnaptysBio's Upsized IPO Raises $75 Million

San Diego biotech AnaptysBio ended up raising $75 million in an upsized initial public offering Jan. 26, making it the first biotech in the country to go public this year.

By Brittany Meiling January 27, 2017 11:08 a.m. share »